Patent · US Active

Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)

US11938201B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Xing Yang · Baltimore, US
Sridhar Nimmagadda · Baltimore, US
Steven Rowe · Burkville, US
Stephanie Slania · Baltimore, US
Martin G. Pomper · Baltimore, US

Key dates

Filing date	Jul 18, 2023
Grant date	Mar 26, 2024
Priority date	—
Expiry date	Jul 18, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K51/0497
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α) and their use in imaging and treating FAP-α related diseases and disorders are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.